Abortion

This survey looks at the public’s health care priorities for the new Congress, including price transparency, mental health, abortion, Medicaid, and health costs. It also looks at the public’s views of the main health provisions in the Inflation Reduction Act (IRA), including on Medicare drug prices.

If Roe v. Wade is overturned, many states will quickly move to restrict or ban abortions. People seeking an abortion who live in those states may be able to access medication abortion via telehealth if their state does not restrict it and if they are within the first 10 weeks of pregnancy.

This factsheet provides an overview of medication abortion, with a focus on federal and state regulations pertaining to its provision and coverage, and the role of the drug in self-managed abortions.

As the nation marks the 50th anniversary of the Supreme Court of the United States landmark Roe v. Wade decision, which the Supreme Court overturned, 14 states have active litigation challenging state abortion bans and restrictions. A new KFF brief explains how individuals and organizations suing to block the bans…

This issue brief presents an overview of the legal challenges presented in state courts since the Dobbs ruling in June 2022 and highlights some of the novel strategies that are being used to defend access to abortion in states that have enacted abortion bans.

This report answers some key questions about abortion in the United States and presents data collected before and after the overturn of Roe v. Wade.

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.